FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.21  |  FHIR Version n/a  User: [n/a]

788328006: Polatuzumab vedotin (substance)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 31-Jan 2020. Module: SNOMED CT core module

Descriptions:

Id Description Lang Type Status Case? Module
3779936019 Polatuzumab vedotin en Synonym Active Entire term case insensitive SNOMED CT core module
3779937011 Polatuzumab vedotin (substance) en Fully specified name Active Entire term case insensitive SNOMED CT core module

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Polatuzumab vedotin Has disposition Microtubule inhibitor true Inferred relationship Existential restriction modifier
Polatuzumab vedotin Is a Substance with microtubule inhibitor mechanism of action true Inferred relationship Existential restriction modifier
Polatuzumab vedotin Is a Monoclonal antibody true Inferred relationship Existential restriction modifier
Polatuzumab vedotin Is a Antineoplastic agent true Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group
Product containing polatuzumab vedotin (medicinal product) Has active ingredient True Polatuzumab vedotin Inferred relationship Existential restriction modifier 1
Polatuzumab vedotin Has active ingredient True Polatuzumab vedotin Inferred relationship Existential restriction modifier 1
Product containing polatuzumab vedotin in parenteral dose form (medicinal product form) Has active ingredient True Polatuzumab vedotin Inferred relationship Existential restriction modifier 1
Product containing only polatuzumab vedotin in parenteral dose form (medicinal product form) Has active ingredient True Polatuzumab vedotin Inferred relationship Existential restriction modifier 1
Polatuzumab vedotin 30mg powder for solution for infusion vials 1 vial Has specific active ingredient True Polatuzumab vedotin Inferred relationship Existential restriction modifier
Polivy 30mg powder for concentrate for solution for infusion vials (Roche Products Ltd) Has specific active ingredient True Polatuzumab vedotin Inferred relationship Existential restriction modifier
Polatuzumab vedotin 30mg powder for solution for infusion vials Has specific active ingredient True Polatuzumab vedotin Inferred relationship Existential restriction modifier
Polivy 30mg powder for concentrate for solution for infusion vials (Roche Products Ltd) 1 vial Has specific active ingredient True Polatuzumab vedotin Inferred relationship Existential restriction modifier
Polatuzumab vedotin 140mg powder for solution for infusion vials 1 vial Has specific active ingredient True Polatuzumab vedotin Inferred relationship Existential restriction modifier
Polivy 140mg powder for concentrate for solution for infusion vials (Roche Products Ltd) 1 vial Has specific active ingredient True Polatuzumab vedotin Inferred relationship Existential restriction modifier
Polatuzumab vedotin 140mg powder for solution for infusion vials Has specific active ingredient True Polatuzumab vedotin Inferred relationship Existential restriction modifier
Polivy 140mg powder for concentrate for solution for infusion vials (Roche Products Ltd) Has specific active ingredient True Polatuzumab vedotin Inferred relationship Existential restriction modifier

This concept is not in any reference sets

Back to Start